Molecular Epidemiology of HIV-1 in Ghana: Subtype Distribution, Drug Resistance and Coreceptor Usage.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
31 12 2022
Historique:
received: 08 12 2022
revised: 27 12 2022
accepted: 29 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

The greatest HIV-1 genetic diversity is found in West/Central Africa due to the pandemic’s origins in this region, but this diversity remains understudied. We characterized HIV-1 subtype diversity (from both sub-genomic and full-genome viral sequences), drug resistance and coreceptor usage in 103 predominantly (90%) antiretroviral-naive individuals living with HIV-1 in Ghana. Full-genome HIV-1 subtyping confirmed the circulating recombinant form CRF02_AG as the dominant (53.9%) subtype in the region, with the complex recombinant 06_cpx (4%) present as well. Unique recombinants, most of which were mosaics containing CRF02_AG and/or 06_cpx, made up 37% of sequences, while “pure” subtypes were rare (<6%). Pretreatment resistance to at least one drug class was observed in 17% of the cohort, with NNRTI resistance being the most common (12%) and INSTI resistance being relatively rare (2%). CXCR4-using HIV-1 sequences were identified in 23% of participants. Overall, our findings advance our understanding of HIV-1 molecular epidemiology in Ghana. Extensive HIV-1 genetic diversity in the region appears to be fueling the ongoing creation of novel recombinants, the majority CRF02_AG-containing, in the region. The relatively high prevalence of pretreatment NNRTI resistance but low prevalence of INSTI resistance supports the use of INSTI-based first-line regimens in Ghana.

Identifiants

pubmed: 36680168
pii: v15010128
doi: 10.3390/v15010128
pmc: PMC9865111
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : PJT-148621
Pays : Canada

Références

Lancet Infect Dis. 2019 Feb;19(2):143-155
pubmed: 30509777
J Antimicrob Chemother. 2019 May 1;74(5):1408-1416
pubmed: 30668734
Front Microbiol. 2021 Jul 15;12:690647
pubmed: 34335516
J Med Virol. 2004 Jun;73(2):158-66
pubmed: 15122787
AIDS Res Ther. 2009 Dec 03;6:28
pubmed: 19954551
J Biosoc Sci. 2014 May;46(3):332-50
pubmed: 23931547
JAMA. 1998 Jun 24;279(24):1977-83
pubmed: 9643862
Virol J. 2009 Feb 26;6:27
pubmed: 19245688
J Clin Microbiol. 2005 Jan;43(1):406-13
pubmed: 15635002
Retrovirology. 2010 Mar 22;7:23
pubmed: 20307309
Front Microbiol. 2022 Aug 25;13:973771
pubmed: 36090108
J Infect Dis. 2021 Aug 2;224(3):377-388
pubmed: 33202025
Mol Biol Evol. 2013 May;30(5):1188-95
pubmed: 23418397
AIDS Res Hum Retroviruses. 2007 Jan;23(1):144-52
pubmed: 17263644
J Clin Microbiol. 2008 Mar;46(3):887-91
pubmed: 18199789
AIDS. 2004 May 21;18(8):1208-10
pubmed: 15166539
J Infect Dis. 2011 Jan 15;203(2):237-45
pubmed: 21288824
AIDS Anal Afr. 1992 Sep-Oct;2(5):5
pubmed: 12317822
Nature. 2008 Oct 2;455(7213):661-4
pubmed: 18833279
Cell Host Microbe. 2021 Jul 14;29(7):1093-1110
pubmed: 34242582
Virology. 1998 Feb 15;241(2):181-8
pubmed: 9499793
AIDS Rev. 2006 Apr-Jun;8(2):60-77
pubmed: 16848274
Demogr Res. 2014 Oct 10;31:861-888
pubmed: 25364298
J Clin Virol. 2007 Oct;40(2):163-7
pubmed: 17827059
J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):599-606
pubmed: 18645511
Lancet HIV. 2021 Feb;8(2):e106-e113
pubmed: 33539757
Antimicrob Agents Chemother. 2000 Sep;44(9):2475-84
pubmed: 10952598
AIDS Res Ther. 2022 May 25;19(1):21
pubmed: 35614510
J Med Microbiol. 2017 Nov;66(11):1663-1672
pubmed: 29068286
J Mol Evol. 1981;17(6):368-76
pubmed: 7288891
J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):376-9
pubmed: 26959188
Ghana Med J. 2017 Mar;51(1):20-23
pubmed: 28959068
Nature. 1993 Oct 14;365(6447):671-3
pubmed: 8413632
Ann Glob Health. 2021 Jun 18;87(1):49
pubmed: 34164262
J Infect Dis. 2005 Aug 1;192(3):466-74
pubmed: 15995960
Epidemiol Infect. 2019 Jan;147:e181
pubmed: 31063103
AIDS Rev. 2003 Jan-Mar;5(1):52-61
pubmed: 12875108
BMC Public Health. 2016 Nov 3;16(1):1136
pubmed: 27809824
BMC Public Health. 2020 May 24;20(1):751
pubmed: 32448210
AIDS Res Hum Retroviruses. 1995 Nov;11(11):1413-6
pubmed: 8573400
SAGE Open Med. 2021 Jul 31;9:20503121211036142
pubmed: 34377475
PLoS One. 2009;4(3):e4724
pubmed: 19266092
AIDS Behav. 2022 Aug;26(8):2653-2663
pubmed: 35122579
Bioinformatics. 2001 May;17(5):415-8
pubmed: 11331235
Nucleic Acids Res. 2003 Jul 1;31(13):3850-5
pubmed: 12824435
J Antimicrob Chemother. 2015 Mar;70(3):930-40
pubmed: 25336166
Open AIDS J. 2016 Apr 08;10:34-48
pubmed: 27347270
AIDS. 2008 Jul 31;22(12):1417-23
pubmed: 18614864
Genome Biol. 2021 Jul 19;22(1):212
pubmed: 34281604
Lancet Infect Dis. 2013 Jul;13(7):622-8
pubmed: 23726798
Nat Biotechnol. 2007 Dec;25(12):1407-10
pubmed: 18066037
Bioinformatics. 2015 Jul 15;31(14):2374-6
pubmed: 25725497
J Clin Microbiol. 2009 Jul;47(7):2292-4
pubmed: 19439544
J Infect Dis. 2008 Mar 15;197(6):867-70
pubmed: 18269317
PLoS One. 2013 Aug 19;8(8):e71972
pubmed: 23977189
Nucleic Acids Res. 2016 Jul 8;44(W1):W232-5
pubmed: 27084950
J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):319-322
pubmed: 31693506
J Clin Microbiol. 2012 Jun;50(6):1936-42
pubmed: 22403431
Curr Opin HIV AIDS. 2022 Jul 1;17(4):222-228
pubmed: 35762377
Science. 2014 Oct 3;346(6205):56-61
pubmed: 25278604
HIV Med. 2006 Oct;7(7):442-50
pubmed: 16925730
Ghana Med J. 2019 Mar;53(1):59-62
pubmed: 31138945
J Int AIDS Soc. 2022 Jul;25 Suppl 1:e25908
pubmed: 35818873
AIDS Rev. 2017 Oct-Dec;19(4):219-230
pubmed: 28182618
N Engl J Med. 2008 Apr 10;358(15):1590-602
pubmed: 18403767
J Intern Med. 2011 Dec;270(6):520-31
pubmed: 21929694
Lancet Infect Dis. 2011 Jan;11(1):45-56
pubmed: 21126914
Virol J. 2020 Jul 24;17(1):114
pubmed: 32709248
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Clin Infect Dis. 2013 Jun;56(11):1667-74
pubmed: 23446628
Curr Opin HIV AIDS. 2019 May;14(3):153-160
pubmed: 30882484
Viruses. 2020 Jun 27;12(7):
pubmed: 32605062
Afr J AIDS Res. 2021 Oct;20(3):204-213
pubmed: 34517791
Retrovirology. 2006 Jul 03;3:40
pubmed: 16817969
AIDS. 2003 Dec 5;17(18):2547-60
pubmed: 14685049
Clin Infect Dis. 2006 Jun 1;42(11):1608-18
pubmed: 16652319
AIDS Res Ther. 2013 Dec 13;10(1):30
pubmed: 24330537

Auteurs

Anna Appah (A)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada.

Charlotte J Beelen (CJ)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada.

Don Kirkby (D)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada.

Winnie Dong (W)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada.

Aniqa Shahid (A)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada.

Brian Foley (B)

Los Alamos National Laboratory, P.O. Box 1663, Los Alamos, NM 87545, USA.

Miriam Mensah (M)

Fevers Unit, Department of Medicine, Korle Bu Teaching Hospital, Accra P.O. Box KB 77, Ghana.

Vincent Ganu (V)

Department of Internal Medicine, Korle Bu Teaching Hospital, Accra P.O. Box KB 77, Ghana.

Peter Puplampu (P)

Department of Internal Medicine, Korle Bu Teaching Hospital, Accra P.O. Box KB 77, Ghana.

Linda E Amoah (LE)

Noguchi Memorial Institute for Medical Research, University of Ghana, Accra P.O. Box LG 581, Ghana.

Nicholas I Nii-Trebi (NI)

Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra P.O. Box LG 25, Ghana.

Chanson J Brumme (CJ)

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada.
Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Zabrina L Brumme (ZL)

Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH